Maternal diet-induced obesity during suckling period programs offspring obese phenotype and hypothalamic

Rodrigo Mello Gomes1, Fernanda Giacomini Bueno2, Christiano Rodrigues Schamber3

  • 1Department of Physiological Sciences, Federal University of Goiás, Goiânia, GO, Brazil.

Insights

Maternal obesity during lactation programs offspring for metabolic syndrome. Obese rat offspring exhibit overweight, insulin resistance, and impaired hypothalamic leptin/insulin signaling, indicating developmental programming of metabolic disease.

Area of Science:

  • Reproductive biology
  • Metabolic disease research
  • Developmental programming

Background:

  • Early life nutrition and hormonal changes can program offspring for metabolic diseases.
  • Maternal obesity during lactation is a potential risk factor for offspring metabolic dysfunction.
  • Understanding the impact of maternal diet on offspring metabolic health is crucial.

Purpose of the Study:

  • To investigate if maternal obesity during lactation programs offspring towards metabolic syndrome and obesity.
  • To assess peripheral glucose metabolism in offspring exposed to maternal obesity.
  • To analyze hypothalamic leptin and insulin signaling pathways in offspring of obese mothers.

Main Methods:

  • Female Wistar rats were divided into control and diet-induced obesity (DIO) groups during lactation.
  • Offspring were fed a standard diet post-weaning until 91 days old.
  • Measurements included body fat, glucose metabolism, insulin resistance, pancreatic function, and hypothalamic signaling pathways.

Main Results:

  • DIO dams showed increased body fat and insulin resistance, with altered breast milk composition.
  • DIO offspring were overweight, hyperphagic, and had higher adiposity, hyperinsulinemia, and insulin resistance.
  • DIO offspring displayed pancreatic islet hypertrophy, increased beta-cell proliferation, and impaired hypothalamic leptin/insulin signaling (reduced ObRb, JAK2, STAT-3, IRβ, PI3K, Akt; increased NPY, decreased POMC).

Conclusions:

  • Maternal obesity during lactation malprograms rat offspring, leading to obesity and metabolic syndrome.
  • Offspring exhibit impaired glucose homeostasis and both peripheral and central insulin resistance.
  • The study highlights the critical role of the maternal lactation environment in metabolic programming and melanocortin system function.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.3K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
268
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
286
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
190
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
66.2K
The Periodic Table03:25

The Periodic Table

As early chemists discovered more elements, they realized that various elements could be grouped by their similar chemical behaviors. One such grouping includes lithium (Li), sodium (Na), and potassium (K). All of these elements are shiny, conduct heat and electricity well, and have similar chemical properties. A second grouping includes calcium (Ca), strontium (Sr), and barium (Ba), which also are shiny, good conductors of heat and electricity, and have chemical properties in common. However,...
115.9K